SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 25 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $12,445,000 | -15.9% | 5,022,000 | +14.1% | 0.03% | -13.5% |
| Q3 2014 | $14,790,000 | -49.7% | 4,401,000 | -59.9% | 0.04% | +8.8% |
| Q2 2014 | $29,414,000 | +199.2% | 10,988,000 | +151.1% | 0.03% | +54.5% |
| Q1 2014 | $9,832,000 | +53.7% | 4,376,000 | +34.9% | 0.02% | +57.1% |
| Q4 2013 | $6,397,000 | +30.8% | 3,243,000 | +1.6% | 0.01% | +27.3% |
| Q3 2013 | $4,892,000 | +7.6% | 3,191,000 | +7.2% | 0.01% | 0.0% |
| Q2 2013 | $4,547,000 | – | 2,977,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 219,440,000 | $737,019,000 | 9.28% |
| SYMPHONY ASSET MANAGEMENT LLC | 11,727,000 | $39,469,000 | 4.07% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,088,000 | $111,210,000 | 2.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 28,200,000 | $94,629,000 | 1.25% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 600,000 | $2,011,000 | 0.79% |
| BNP PARIBAS FINANCIAL MARKETS | 1,200,000 | $402,672,000,000 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 3,000,000 | $10,148,000 | 0.11% |
| Visium Asset Management, LP | 2,000,000 | $6,737,000 | 0.10% |
| SG Americas Securities, LLC | 22,800 | $7,662,000 | 0.04% |
| CITIGROUP INC | 13,009,000 | $43,653,000 | 0.04% |